Bristol-Myers Squibb | BMY - Umsatzkosten

Aktienkurs
59.20
Täglich Wechseln
1.53 2.65%
Monatlich
-2.36%
Jährlich
10.16%
Q2 Prognose
57.81




Umsatzkosten Veränderung Datum
AbbVie USD 4.55B 757M 2025-12
Abbott USD 4.92B 535M 2025-12
ALKERMES USD 46.21M 5.38M 2025-12
Amgen USD 1.79B 128M 2025-12
AstraZeneca USD 3.27B 471M 2025-12
Biogen USD 810.1M 205.1M 2025-09
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Coherus Biosciences USD 4.04M 324K 2025-12
Drreddys Laboratories INR 40.46B 3.64B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
J&J USD 7.97B 689M 2025-12
Medtronic USD 3.61B 83M 2025-12
Merck USD 3.32B 531M 2025-12
Novartis USD 3.54B 3M 2025-12
Novo Nordisk DKK 15.15B 2.3B 2025-12
Perrigo USD 747.4M 81.2M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Phibro Animal Health USD 240.42M 2.58M 2025-12
Prestige Brands USD 131.22M 3.52M 2025-12
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 4.29B 421M 2025-12
Sanofi EUR 3.76B 344M 2025-12
United Therapeutics USD 474.7M 373.8M 2025-12
Zoetis USD 743M 60M 2025-12